September 19 2019
Dear NRG Principal Investigators,
We were recently asked to provide a letter to support an NRG Oncology investigator’s response to a query at their institution related to a study not meeting the accrual threshold for remaining open. You likely have some experience with being questioned about maintaining an open study that doesn’t appear to be accruing due to the rare-tumor type involved. We agreed to pull together a letter to provide support, and thought to share this more broadly.
We appreciate the challenge arising from keeping studies open that don’t appear to be accruing well locally, and hope that in the case of rare-tumor types exceptions are made. We are very willing to support your local efforts, however it is important to ensure every eligible patient has an opportunity to participate.
We hope this is helpful, and appreciate your commitment to NRG Oncology.
Walter J. Curran, Jr., MD
Robert Mannel, MD
Norman Wolmark, MD